Heron Therapeutics (HRTX) Shares Outstanding: 2010-2025
Historic Shares Outstanding for Heron Therapeutics (HRTX) over the last 8 years, with Sep 2025 value amounting to $183.3 million.
- Heron Therapeutics' Shares Outstanding rose 20.84% to $183.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $183.3 million, marking a year-over-year increase of 20.84%. This contributed to the annual value of $152.1 million for FY2024, which is 1.23% up from last year.
- As of Q3 2025, Heron Therapeutics' Shares Outstanding stood at $183.3 million, which was up 19.62% from $153.3 million recorded in Q2 2025.
- In the past 5 years, Heron Therapeutics' Shares Outstanding registered a high of $183.3 million during Q3 2025, and its lowest value of $91.4 million during Q1 2021.
- For the 3-year period, Heron Therapeutics' Shares Outstanding averaged around $147.8 million, with its median value being $151.6 million (2024).
- Data for Heron Therapeutics' Shares Outstanding shows a peak YoY rose of 26.36% (in 2024) over the last 5 years.
- Heron Therapeutics' Shares Outstanding (Quarterly) stood at $102.0 million in 2021, then grew by 16.81% to $119.2 million in 2022, then rose by 26.13% to $150.3 million in 2023, then rose by 1.23% to $152.1 million in 2024, then rose by 20.84% to $183.3 million in 2025.
- Its last three reported values are $183.3 million in Q3 2025, $153.3 million for Q2 2025, and $152.4 million during Q1 2025.